Eagle Pharmaceuticals Revenue 2013-2019 | EGRX

Eagle Pharmaceuticals revenue from 2013 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Eagle Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $213
2017 $237
2016 $189
2015 $66
2014 $
2014 $19
2013 $14
2012 $
2012 $3
2011 $3
Eagle Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $41
Q2 2019 $57
Q1 2019 $50
Q4 2018 $56
Q3 2018 $51
Q2 2018 $59
Q1 2018 $47
Q4 2017 $47
Q3 2017 $63
Q2 2017 $50
Q1 2017 $77
Q4 2016 $81
Q3 2016 $38
Q2 2016 $41
Q1 2016 $30
Q4 2015 $18
Q3 2015 $6
Q2 2015 $6
Q1 2015 $36
Q4 2014 $6
Q3 2014 $3
Q2 2014 $6
Q1 2014 $5
Q4 2013 $5
Q3 2013 $5
Q2 2013 $5
Q1 2013 $2
Q3 2012
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.797B $0.213B
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.152B 27.21
Medtronic (MDT) Ireland $145.746B 20.46
Stryker (SYK) United States $74.888B 25.18
Boston Scientific (BSX) United States $57.453B 27.12
Baxter (BAX) United States $40.896B 24.80
EssilorLuxottica Societe Anonyme (ESLOY) France $32.537B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.730B 18.65
Terumo (TRUMY) Japan $26.750B 33.38
Coloplast (CLPBY) Denmark $25.121B 40.10
Lonza Group Ag (LZAGY) Switzerland $24.554B 0.00
ResMed (RMD) United States $20.727B 38.24
Smith & Nephew SNATS (SNN) United Kingdom $18.483B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.961B 521.47
Bio-Rad Laboratories (BIO) United States $10.558B 50.68
Hill-Rom Holdings (HRC) United States $6.990B 20.59
Canopy Growth (CGC) Canada $6.705B 0.00
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.573B 12.26
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.116B 41.33
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.780B 29.76
ICU Medical (ICUI) United States $3.692B 24.08
Aurora Cannabis (ACB) Canada $3.673B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.379B 0.00
Neogen (NEOG) United States $3.366B 56.32
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.995B 0.00
Quidel (QDEL) United States $2.491B 23.64
National Vision Holdings (EYE) United States $2.138B 48.26
Agios Pharmaceuticals (AGIO) United States $2.001B 0.00
Cardiovascular Systems (CSII) United States $1.547B 0.00
InMode (INMD) Israel $1.405B 0.00
VAREX IMAGING (VREX) United States $1.255B 25.13
Aphria (APHA) $1.195B 0.00
AtriCure (ATRC) United States $1.111B 0.00
Phibro Animal Health (PAHC) United States $0.921B 17.24
NanoString Technologies (NSTG) United States $0.824B 0.00
Lantheus Holdings (LNTH) United States $0.824B 20.58
TG Therapeutics (TGTX) United States $0.718B 0.00
LeMaitre Vascular (LMAT) United States $0.683B 38.39
Omeros (OMER) United States $0.675B 0.00
PetIQ (PETQ) United States $0.632B 15.45
Quanterix (QTRX) United States $0.628B 0.00
Cerus (CERS) United States $0.601B 0.00
HEXO (HEXO) $0.545B 0.00
Surmodics (SRDX) United States $0.531B 55.44
OraSure Technologies (OSUR) United States $0.507B 30.41
Organigram Holdings (OGI) Canada $0.426B 0.00
Owens & Minor (OMI) United States $0.422B 15.60
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.376B 27.22
Meridian Bioscience (VIVO) United States $0.348B 11.98
BioLife Solutions (BLFS) United States $0.338B 138.25
Zynex (ZYXI) United States $0.298B 33.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.289B 0.00
Bovie Medical (APYX) United States $0.271B 0.00
Viemed Healthcare (VMD) United States $0.258B 0.00
United Health Products (UEEC) United States $0.214B 0.00
Vapotherm (VAPO) United States $0.200B 0.00
Repro-Med Systems (KRMD) United States $0.174B 0.00
InfuSystems Holdings (INFU) United States $0.144B 0.00
Cytosorbents (CTSO) United States $0.142B 0.00
Fonar (FONR) United States $0.131B 9.24
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.109B 0.00
United-Guardian (UG) United States $0.088B 22.30
Chembio Diagnostics (CEMI) United States $0.077B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Surface Oncology (SURF) United States $0.047B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.045B 0.00
MTech Acquisition (KERN) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.022B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00